Preferred Stock Offerings
By Ru Back Packer Staff, updated Thursday, February 1, 7:11 AM
Slide #187. Actavis plc — Preferred Stock Offering
||Actavis plc (NASDAQ:ACT)
|Date of Pricing:
|Price Per Share:
|Preferred Stock Offering Details:
||Actavis plc (NYSE: ACT) today announced that it is commencing concurrent offerings totaling $8.4 billion, comprising $4.2 billion of Ordinary Shares and $4.2 billion of Mandatory Convertible Preferred Shares, Series A, each in a separate registered public offering, subject to market and other conditions. - updated 2/25 - Actavis plc (NYSE: ACT) today announced that it has priced its concurrent offerings of 13,194,445 Ordinary Shares at $288.00 per share and 4,600,000 5.500% Mandatory Convertible Preferred Shares, Series A, at $1,000.00 per share, each being offered in a separate registered public offering.
Actavis is a pharmaceutical company engaged in the development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products. Co. also develops and out-licenses generic pharmaceutical products primarily in Europe through its Medis third-party business. Co. has three reporting segments which includes Actavis Pharma, Actavis Specialty Brands, and Anda Distribution. As of Dec 31 2013, Co.'s portfolio included approximately 250 generic pharmaceutical product families and approximately 45 brand pharmaceutical product families.
Open the ACT Page at Ru Back Packer »
Open the ACT Page at Ru Back Packer (in a new window) »